Surface plasmon resonance biosensor technology — enabling real-time label-free measurement of protein-protein, protein-drug, and protein-nucleic acid interaction kinetics and affinity — represents one of the most powerful protein chip applications, with the US Protein Chip Market reflecting the broad adoption of Cytiva's Biacore instruments, Bruker's Sierra SPR, and competing platforms in pharmaceutical drug discovery, antibody characterization, and mechanistic biology research.

SPR measures the refractive index change at a sensor chip surface as molecules bind to immobilized ligands — detecting binding in real time without labels through the evanescent field sensitivity that mass accumulation at the gold-coated sensor surface creates. The resulting sensorgram directly reports association rate constant (ka), dissociation rate constant (kd), and equilibrium dissociation constant (KD) that characterize binding kinetics and affinity with a depth of information that endpoint binding assays cannot provide.

Antibody characterization by SPR — measuring antigen binding affinity, off-rate, epitope competition, and Fc receptor binding for therapeutic antibody development — has become a standard analytical tool in biopharmaceutical development, with regulatory submissions for therapeutic antibodies expected to include SPR-derived binding characterization data supporting proposed mechanism of action.

Therapeutic drug candidate screening by SPR — using fragment-based drug discovery to identify small molecule binders to target proteins and characterize structure-activity relationships through SPR binding kinetics — enables physicochemical property optimization during drug discovery that cell-based assays cannot provide directly. The kinetic selectivity that SPR distinguishes — compounds with equivalent affinity but different on- and off-rates having potentially different in vivo pharmacological profiles — guides selectivity optimization that affinity measurement alone cannot direct.

Do you think SPR will be displaced by biolayer interferometry as the preferred label-free biosensor technology for antibody characterization in biopharmaceutical development?

FAQ

What is surface plasmon resonance in protein analysis? SPR measures real-time label-free protein binding by detecting refractive index changes at a sensor surface as molecules associate and dissociate, providing association rate, dissociation rate, and equilibrium affinity constants characterizing molecular interaction kinetics.

What is Biacore used for in drug discovery? Biacore SPR instruments measure binding kinetics and affinity for drug candidates against target proteins, characterize therapeutic antibody binding properties, and support structure-activity relationship studies in pharmaceutical drug discovery programs.

#USProteinChip #SPRbiosensor #Biacore #ProteinInteraction #DrugDiscovery #AntibodyCharacterization